This is an old revision of this page, as edited by Citation bot(talk | contribs) at 23:22, 10 February 2024(Add: doi-access, title, authors 1-1. Removed proxy/dead URL that duplicated identifier. Changed bare reference to CS1/2. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by Ira Leviton | Category:CS1 maint: unflagged free DOI | #UCB_Category 2/67). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 23:22, 10 February 2024 by Citation bot(talk | contribs)(Add: doi-access, title, authors 1-1. Removed proxy/dead URL that duplicated identifier. Changed bare reference to CS1/2. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by Ira Leviton | Category:CS1 maint: unflagged free DOI | #UCB_Category 2/67)
α3IA, also known as GTPL4094 is a inverse agonist of the GABAA receptor. It is more selctive for the α3 subunit, hence its name.
Effects
Agonism of the α3 subunit shows anxiolytic properties. However, by being an inverse agonist, α3IA has the opposite action: it shows anxiogenic properties.[2]
This compound also has affinity for the other subunits of the GABAA receptor, but it is more selective for the α3 subunit.[3]